Boston Scientific Global Supply Chain FinOps Reporting Manager 

United States, Massachusetts, Marlborough 

953867942

About the role:

This role reports to the FinOps Associate Director Lead and requires limited travel as needed for team coordination or stakeholder meetings. The position could be located in multiple BSC locations.

Key responsibilities include:

• Lead the GSC FinOps standardized reporting function, including mentoring a global team of Reporting and BI Analysts; provide coaching, guidance, and performance development
• Partner with Finance Forward and Global HQ FinOps teams on standing up the new capability
• Set longer term strategic roadmap for maturation of GSC finance reporting needs
• Develop and oversee reporting templates, KPIs, governance model, and reporting cadence
• Partner with all stakeholders including plant controllers and IT to ensure reporting meets evolving business needs
• Design and implement dashboards that enable self-service access to key financial metrics
• Oversee the transition of reporting responsibilities from site-level teams into the FinOps team, including process discovery, documentation, and stakeholder alignment
• Develop, document, and maintain SOPs, control frameworks, and audit compliance for FinOps-owned reports
• Define and track performance KPIs for the reporting function; drive continuous improvement initiatives

Required Qualifications:

• Bachelor’s degree in Accounting, Finance, Data Analytics or a related field
• 6+ years of experience in reporting, finance, supply chain analytics, or FP&A roles, preferably within manufacturing, medical device, or pharmaceutical industries
• Minimum 3 years in a leadership role managing teams and cross-functional stakeholders
• Familiarity with shared services or COE models
• Experience in inventory management, cost accounting, and inventory reporting
• Technical knowledge of reporting tools, data architecture, and inventory KPIs
• Proven experience building and scaling inventory or operational reporting in a global environment
• Hands-on experience with ERP systems, BI tools (Power BI, Tableau), and data platforms
• Verbal and written communication skills in both local language and English
• Strong leadership and interpersonal skills to manage a diverse, global team
• Advanced experience with MS power tools such as Power Query, Power Pivot, and Power BI
• Strong project management and change management capabilities

Preferred Qualifications:

• MBA degree preferred
• Experience working in ERP systems and financial data tools like Hyperion
• Experience leading large-scale process discovery, documentation and standardized planning initiatives
• Proven ability to lead process improvement and technology adoption initiatives

Compensation fornon-exempt (hourly), non-sales rolesmay also include variable compensation from time to time (e.g., any overtime and shift differential) and annual bonus target (subject to plan eligibility and other requirements).

Compensation forexempt, non-sales rolesmay also include variable compensation, i.e., annual bonus target and long-term incentives (subject to plan eligibility and other requirements).

For MA positions:It is unlawful to require or administer a lie detector test for employment. Violators are subject to criminal penalties and civil liability.

Please be advised that certain US based positions, including without limitation field sales and service positions that call on hospitals and/or health care centers, require acceptable proof of COVID-19 vaccination status. Candidates will be notified during the interview and selection process if the role(s) for which they have applied require proof of vaccination as a condition of employment. Boston Scientific continues to evaluate its policies and protocols regarding the COVID-19 vaccine and will comply with all applicable state and federal law and healthcare credentialing requirements. As employees of the Company, you will be expected to meet the ongoing requirements for your roles, including any new requirements, should the Company’s policies or protocols change with regard to COVID-19 vaccination.